Goldrekord:
Warum dieser dritte Anstieg anders ist und wie man profitieren kann
Anzeige
REGENXBIO INC. DL-,0001 WKN: A140E0 ISIN: US75901B1070 Kürzel: RB0 Forum: Aktien Thema: Hauptdiskussion
11,55 EUR
-0,43 %-0,05
14. Sep, 13:00:52 Uhr,
Lang & Schwarz
Kommentare 86
Summer.76,
2. Aug 3:36 Uhr
0
https://ir.regenxbio.com/news-releases/news-release-details/regenxbio-announces-new-positive-data-affinity-duchenner-trial
Summer.76,
2. Aug 3:36 Uhr
0
https://ir.regenxbio.com/news-releases/news-release-details/regenxbio-reports-second-quarter-2024-financial-results-and
Summer.76,
07.03.2024 8:12 Uhr
0
https://www.prnewswire.com/news-releases/regenxbio-announces-pricing-of-upsized-public-offering-of-common-stock-and-pre-funded-warrants-302082361.html
Summer.76,
05.03.2024 13:44 Uhr
0
🍀
Summer.76,
05.03.2024 13:43 Uhr
0
https://www.prnewswire.com/news-releases/regenxbio-announces-new-positive-initial-efficacy-data-from-affinity-duchenne-trial-302079525.html
Summer.76,
27.02.2024 22:09 Uhr
0
https://regenxbio.gcs-web.com/news-releases/news-release-details/regenxbio-reports-fourth-quarter-and-full-year-2023-financial
Summer.76,
07.02.2024 19:01 Uhr
0
https://regenxbio.gcs-web.com/news-releases/news-release-details/regenxbio-announces-pivotal-trial-rgx-121-treatment-mps-ii
Summer.76,
07.02.2024 19:01 Uhr
0
https://regenxbio.gcs-web.com/news-releases/news-release-details/regenxbio-announces-completion-enrollment-cohort-2-and
Summer.76,
04.10.2023 5:15 Uhr
0
REGENXBIO Presents Interim Clinical Data from Phase I/II AFFINITY DUCHENNE™ Trial of RGX-202 at 28th Annual International Congress of the World Muscle Society
https://www.prnewswire.com/news-releases/regenxbio-presents-interim-clinical-data-from-phase-iii-affinity-duchenne-trial-of-rgx-202-at-28th-annual-international-congress-of-the-world-muscle-society-301946289.html
Summer.76,
02.08.2023 22:07 Uhr
0
https://www.prnewswire.com/news-releases/regenxbio-reports-second-quarter-2023-financial-results-and-recent-operational-highlights-301891935.html
Summer.76,
03.05.2023 22:10 Uhr
0
https://regenxbio.gcs-web.com/news-releases/news-release-details/regenxbio-reports-first-quarter-2023-financial-results-and
Summer.76,
11.04.2023 15:10 Uhr
0
https://www.prnewswire.com/news-releases/regenxbio-receives-fda-fast-track-designation-for-rgx-202-a-novel-gene-therapy-candidate-for-the-treatment-of-duchenne-muscular-dystrophy-301794029.html
Solix,
11.04.2023 13:07 Uhr
0
🎈
Summer.76,
28.02.2023 22:07 Uhr
0
https://www.prnewswire.com/news-releases/regenxbio-reports-fourth-quarter-2022-and-full-year-2022-financial-results-and-recent-operational-highlights-301758593.html
Summer.76,
22.02.2023 22:41 Uhr
0
https://www.prnewswire.com/news-releases/additional-positive-interim-data-from-phase-iiiiii-campsiite-trial-of-regenxbios-rgx-121-for-the-treatment-of-mps-ii-hunter-syndrome-presented-at-19th-annual-worldsymposiumtm-301753564.html
Summer.76,
11.02.2023 22:48 Uhr
0
https://www.prnewswire.com/news-releases/regenxbio-presents-interim-data-from-phase-ii-bridging-study-evaluating-the-clinical-performance-of-rgx-314-using-the-navxpress-manufacturing-platform-process-301744570.html
Meistdiskutiert
|
|
Thema | ||
|---|---|---|---|
| 1 | Gme sinnvoller austausch der apes | -0,06 % | |
| 2 | Börsen Comedy | ||
| 3 | Gamestop💎🙌 | -0,06 % | |
| 4 | HELLOFRESH SE INH O.N. Hauptdiskussion | +2,81 % | |
| 5 | AMC ENTERTAINMENT Hauptdiskussion | -0,22 % | |
| 6 | BASF Hauptdiskussion | ±0,00 % | |
| 7 | BP Hauptdiskussion | ±0,00 % | |
| 8 | MICROSTRATEGY Hauptdiskussion | +0,88 % | |
| 9 | TradingBulls | ||
| 10 | Diversified Energy Company (DEC) | ±0,00 % | Alle Diskussionen |
Aktien
|
|
Thema | ||
|---|---|---|---|
| 1 | Gme sinnvoller austausch der apes | -0,06 % | |
| 2 | Gamestop💎🙌 | -0,06 % | |
| 3 | HELLOFRESH SE INH O.N. Hauptdiskussion | +2,81 % | |
| 4 | AMC ENTERTAINMENT Hauptdiskussion | -0,22 % | |
| 5 | BASF Hauptdiskussion | ±0,00 % | |
| 6 | BP Hauptdiskussion | ±0,00 % | |
| 7 | MICROSTRATEGY Hauptdiskussion | +0,88 % | |
| 8 | MicroStrategy | +0,88 % | |
| 9 | FREYR BATTERY | ±0,00 % | |
| 10 | Lilium Aktie | -1,41 % | Alle Diskussionen |